Kai Chen received the 1st place student paper award from the ASA Biopharmaceutical Section
Kai Chen shared a post on LinkedIn:
“It is a great honor to receive the 1st place student paper award from the ASA Biopharmaceutical Section, along with a special thanks for the $2,000 cash reward! Presenting my work at JSM provided an incredible opportunity to meet and learn from talented and experienced experts from the FDA, industry, and academia.
I am thrilled to share the paper that enhances the operating characteristics of the BOP2 design when jointly monitoring toxicity and efficacy in phase II trials. We have developed an analytic solution for Type I error calculation that notably improves both accuracy and computational efficiency.
The software is freely available here. To the best of our knowledge, over 50 phase II or I-II trials at MD Anderson Cancer Center are based on BOP2 design. I am deeply grateful to my advisor, Dr. Ying Yuan, for his invaluable guidance, support, and expertise in clinical trial design.”
Source: Kai Chen/LinkedIn
Authors: Kai Chen, Heng Zhou, Jack Lee, Ying Yuan.
Kai Chen is a Research Assistant at MD Anderson Cancer Center, where he contributes to oncology research projects. He has participated in the FDA-OCE-ASA Oncology Educational Fellowship and has been a Biostatistics Intern at Takeda.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023